International Biotechnology Trust’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-441,019
| Closed | -$6.77M | – | 69 |
|
|
2023
Q2 | $6.77M | Buy |
441,019
+300,000
| +213% | +$4.61M | 2.06% | 17 |
|
|
2023
Q1 | $3.17M | Sell |
141,019
-238,000
| -63% | -$5.35M | 0.88% | 33 |
|
|
2022
Q4 | $7.96M | Buy |
379,019
+193,000
| +104% | +$4.05M | 2.46% | 16 |
|
|
2022
Q3 | $4.58M | Buy |
186,019
+176,804
| +1,919% | +$4.36M | 1.47% | 23 |
|
|
2022
Q2 | $380K | Sell |
9,215
-370,785
| -98% | -$15.3M | 3.96% | 7 |
|
|
2022
Q1 | $1.55M | Hold |
380,000
| – | – | 0.35% | 47 |
|
|
2021
Q4 | $11.8M | Hold |
380,000
| – | – | 2.63% | 12 |
|
|
2021
Q3 | $9.22M | Buy |
380,000
+360,000
| +1,800% | +$8.73M | 2.22% | 16 |
|
|
2021
Q2 | $292K | Hold |
20,000
| – | – | 0.08% | 64 |
|
|
2021
Q1 | $499K | Hold |
20,000
| – | – | 0.13% | 53 |
|
|
2020
Q4 | $545K | Buy |
+20,000
| New | +$545K | 0.15% | 48 |
|
|
2019
Q3 | – | Sell |
-18,000
| Closed | -$362K | – | 63 |
|
|
2019
Q2 | $362K | Sell |
18,000
-190,000
| -91% | -$3.82M | 0.13% | 63 |
|
|
2019
Q1 | $4.7M | Buy |
+208,000
| New | +$4.7M | 1.74% | 22 |
|